Skip to main content
. Author manuscript; available in PMC: 2011 Nov 11.
Published in final edited form as: J Med Chem. 2010 Nov 11;53(21):7467–7489. doi: 10.1021/jm901742e

Table 1.

IC50 (antagonists) or EC50 (agonists) values for compounds in Figure 6 against three bacterial strains. All values reported in µM. A blank entry indicates the value was not determined.

Compound P. aeruginosa
LasRa,d
A. tumefaciens
TraRb
V. fischeri
LuxRc,e
Antagonists
  3-oxo-C8-HSL 0.11
  C10-HSL 0.25 1.05 0.40
  27 0.34 0.92 1.35
  28 1.72 1.25 0.86
  C8-HSL 1.75 0.77 0.77
  30 4.67 0.46
  4 0.69 1.36
  29 0.81 0.61
Agonists
  3-oxo-C14-HSL 0.01
  C12-HSL 0.04
  32 0.54
  31
a

Antagonism assay performed using an E. coli LasR reporter strain in the presence of 7.5 nM 3-oxo-C12-HSL.

b

Antagonism assay performed using A. tumefaciens reporter strain in the presence of 100 nM 3-oxo-C8-HSL.

c

Antagonism assay performed using V. fischeri reporter strain in the presence of 5 µM 3-oxo-C6-HSL.

d,e

Agonism assays performed using the appropriate reporter strain in the absence of natural autoinducer.